Schedule 13G ownership disclosure

Soleno Therapeutics Inc

Common Stock · CUSIP: 834203309

Event date: 2025-03-31

Filing-level shares
5,152,669
Percent of class
11.2%
  • JANUS HENDERSON GROUP PLC

    Shares: 5,152,669 · Class: 11.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000135
Form type
SCHEDULE 13G/A
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub